SPOTLIGHT -
How can ophthalmologists better educate patients about the severity of DME progression?
Rising cost of diabetic medications impact individuals as well as Medicaid and Medicare
Opthea highlights latest phase 3 trials for sozinibercept
Dexamethasone and Bevacizumab for DME: Individualized treatment advocated
Less may be more in a real-world study of anti-VEGF therapy for DME
Exonate to present full Phase Ib/IIa trial data of EXN407 for treatment of DR, DME at ARVO
Phase Ib/IIa trial of EXN407 eye drops from Exonate demonstrates safety and tolerability